Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

A freelance cameraman's appendix ruptured and by the time he was admitted to surgery, it was too late. A self-employed mother of two is found dead in bed from undiagnosed heart disease. A 26-year-old aspiring fashion designer collapsed in her bathroom after feeling unusually fatigued for days. What all three of these people have in common is that they experienced symptoms, but didn't seek care because they were uninsured and they worried about the hospital expense, according to their families. All three died. Research released ... in the American Journal of Public Health estimates that 45,000 deaths per year in the United States are associated with the lack of health insurance. If a person is uninsured, "it means you're at mortal risk," said one of the authors, Dr. David Himmelstein, an associate professor of medicine at Harvard Medical School. The researchers examined government health surveys from more than 9,000 people aged 17 to 64, taken from 1986-1994, and then followed up through 2000. They determined that the uninsured have a 40 percent higher risk of death than those with private health insurance as a result of being unable to obtain necessary medical care. The researchers then extrapolated the results to census data from 2005 and calculated there were 44,789 deaths associated with lack of health insurance.

Note: For key reports on important health issues from reliable sources, click here.

A fascinating court case in Australia has been playing out around some people who had heart attacks after taking the Merck drug, Vioxx. This medication turned out to increase the risk of heart attacks in people taking it, although that finding was arguably buried in their research, and Merck has paid out more than Ł2bn to 44,000 people in America. The first ... thing to emerge in the Australian case is email documentation showing staff at Merck made a "hit list" of doctors who were critical of the company, or of the drug. This list contained words such as "neutralise", "neutralised" and "discredit" next to the names of various doctors. "We may need to seek them out and destroy them where they live," said one email, from a Merck employee. Staff are also alleged to have used other tactics, such as trying to interfere with academic appointments, and dropping hints about how funding to institutions might dry up. Worse still, is the revelation that Merck paid the publisher Elsevier to produce a publication. This time Elsevier Australia went the whole hog, giving Merck an entire publication which resembled an academic journal, although in fact it only contained reprinted articles, or summaries, of other articles.

Note: For a superb overview of corruption in the pharmaceutical industry by a leading MD and former medical journal editor, click here.

We have always been told there is no recovery from persistent vegetative state - doctors can only make a sufferer's last days as painless as possible. But is that really the truth? Across three continents, severely brain-damaged patients are awake and talking after taking ... a sleeping pill. Brain-damaged patients are reporting remarkable improvements after taking a pill that should make them fall asleep but that, instead, appears to be waking up cells in their brains that were thought to have been dead. No one yet knows exactly how a sleeping pill could wake up the seemingly dead brain cells, but [researchers] have a hypothesis. After the brain has suffered severe trauma, a chemical known as Gaba (gamma amino butyric acid) closes down brain functions in order to conserve energy and help cells survive. However, in such a long-term dormant state, the receptors in the brain cells that respond to Gaba become hypersensitive, and as Gaba is a depressant, it causes a persistent vegetative state. It is thought that during this process the receptors are in some way changed or deformed so that they respond to zolpidem differently from normal receptors, thus breaking the hold of Gaba. This could mean that instead of sending patients to sleep as usual, it makes dormant areas of the brain function again and some comatose patients wake up.

Note: For lots more on key health issues from reliable sources, click here.

Doctors and patients are being misled about the effectiveness of some drugs because negative trial results are not published, experts have warned. Writing in the British Medical Journal, they say that pharmaceutical companies should be forced to publish all data, not just positive findings. The German team give the example of the antidepressant reboxetine, saying publications have failed to show the drug in a true light. Reboxetine (Edronax), made by Pfizer, is used in many European countries, including the UK. But its rejection by US drug regulators raised doubts about its effectiveness, and led some to hunt for missing data. This is not the first time a large drug company has come under fire about its published drug trial data. Pharmaceutical giant GlaxoSmithKline (GSK) was criticised for failing to raise the alarm on the risk of suicidal behaviour associated with its antidepressant Seroxat. GSK has also been forced to defend itself over allegations about hiding negative data regarding another of its drugs, Avandia, which is used to treat diabetes. "Our findings underline the urgent need for mandatory publication of trial data," [the researchers] say in the BMJ. They warn that the lack of all information means policy makers are unable to make informed decisions. In the US, it is already a requirement that all data - both positive and negative - is published.

Note: For a powerful summary of government/corporate corruption in the pharmaceutical industry by a respected former editor of a major medical journal, click here.

We may be on the path to a new technology in which quite literally, we will be growing new body parts. It's called "regenerative medicine," where cells in the human body are manipulated into regrowing tissue. Researchers have so far created beating hearts, ears and bladders. Biotech companies and the Pentagon have invested hundreds of millions of dollars in research that could profoundly change millions of lives. Dr. Anthony Atala runs the Wake Forest Institute for Regenerative Medicine in North Carolina. You name the body part, chances are Dr. Atala is trying to grow one. "The possibilities really are endless," he said. Atala says every organ in our body contains special stem cells that are unique to each body part. The key to regeneration, he says, is to isolate and then multiply those cells until there are enough to cover a mold of that particular body part. In Pittsburgh, researchers are taking a different approach: at the McGowan Institute for Regenerative Medicine they are trying to trick the body into actually repairing and regenerating itself. Dr. Steven Badylak, the institute's deputy director, [is] convinced that the key to regeneration is finding the switch in our bodies that tells our cells to grow when we are still in the womb. Badylak said. "If we could make the body or at least the part of the body that's missing or injured think that it's an early fetus again. That's game set and match."

Note: Robert Becker did amazing, pioneering research in this field over 25 years ago, yet was shunned by conservative academia. For his landmark book The Body Electric, click here.

In school, Anas Mohammadu's mates call him "horror" and make fun of him. But Anas is lucky to be alive. Other children who were used in the controversial 1996 drug trial by US pharmaceutical giant Pfizer died. Anas, then only three years old, was the first child to be given the experimental antibiotic Trovan at the Infectious Diseases Hospital, Kano, during the drug trial. Pfizer tested the then unregistered drug in Nigeria's north-western Kano State during an outbreak of meningitis which had affected thousands of children. Officials in Kano say more than 50 children died in the experiment, while many others developed mental and physical deformities. But Pfizer says only 11 of the 200 children used in the drug trial died. Following pressure from rights groups and families affected by the trial, the Nigerian government set up an expert medical panel to review the drug trial. The experiment was "an illegal trial of an unregistered drug", the Nigerian panel concluded, and a "clear case of exploitation of the ignorant". After more than a decade of silence, the Nigerian government has decided to sue Pfizer, seeking $7bn (Ł3.5bn) in damages for the families of children who allegedly died or suffered side-effects in the experiment. Kano State government has also filed separate charges against Pfizer.

Note: Pfizer settled the case out of court, as reported by BBC at this link.

Doctors have treated only three leukemia patients, but the sensational results from a single shot could be one of the most significant advances in cancer research in decades. Doctors at the University of Pennsylvania say the treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70 percent in the third. In each of the patients as much as five pounds of cancerous tissue completely melted away in a few weeks, and a year later it is still gone. The results of the preliminary test “exceeded our wildest expectations,” says immunologist Dr. Carl June a member of the Abramson Cancer Center's research team. Chemotherapy and radiation can hold this form of leukemia at bay for years, but until now the only cure has been a bone marrow transplant. A bone marrow transplant requires a suitable match, works only about half the time, and often brings on severe, life-threatening side effects such as pain and infection. So why has this remarkable treatment been tried so far on only three patients? Both the National Cancer Institute and several pharmaceutical companies declined to pay for the research. Neither applicants nor funders discuss the reasons an application is turned down.

Note: For key reports from reliable sources on hopeful new cancer treatments, click here.

There is nothing the state of North Carolina can do, Elaine Riddick says, to make up for forcing her to be sterilized when she was 14 years old. "They cut me open like I was a hog," [she said]. About 7,600 people were sterilized under North Carolina's eugenics program. Roughly 85 percent of the victims were women or girls. Unlike most states, North Carolina ramped up its sterilizations after World War II, despite associations between eugenics and Nazi Germany, which took eugenics to even more horrifying lengths. Around 70 percent of all North Carolina's sterilizations were performed after the war, peaking in the 1950s, according to state records. Nationwide, there were more than 60,000 known victims of sterilization programs, with perhaps another 40,000 sterilized through "unofficial" channels like hospitals or local health departments working on their own initiative. Eugenics was aimed at creating a better society by filtering out people considered undesirable, ranging from criminals to those imprecisely designated as "feeble-minded." People as young as 10 in North Carolina were sterilized for not getting along with schoolmates, being promiscuous or running afoul of local social workers or doctors. "Where did all this come from? This came from doctors, medical practitioners, professors, not guys in pickup trucks wearing white sheets," said Edwin Black, author of the eugenics history War Against the Weak.

It's fraudulent for academics to give their names to medical articles ghostwritten by pharmaceutical industry writers, say two Canadian law professors who call for potential legal sanctions. Studies suggest that industry-driven drug trials and industry-sponsored publications are more likely to downplay a drug's harms and exaggerate a drug's virtues, said Trudo Lemmens, a law professor at the University of Toronto. The integrity of medical research is also harmed by ghostwritten articles, he said. Ghostwriting is part of marketing that can distort the evidence on a drug, Lemmens said. Industry authors are concealed to insert marketing messages and academic experts are recruited as "guest" authors to lend credibility despite not fulfilling criteria for authorship, such as participating in the design of the study, gathering data, analyzing the results and writing up of the findings. Lemmens and his colleague Prof. Simon Stern argue that legal remedies are needed for medical ghostwriting since medical journals, academic institutions and professional disciplinary bodies haven't succeeded in enforcing sanctions against the practice. Ghostwritten publications are used in court to support a manufacturer's arguments about a drug's safety and effectiveness, and academic experts who appear as witnesses for pharmaceutical and medical device companies also boost their credibility with the publications on their CV, Lemmens said.

Note: For a respected doctor's powerful analysis of fraud in the pharmaceutical industry, click here. For lots more from reliable sources on key health issues, click here.

Do drugs really stop working after the date stamped on the bottle? Fifteen years ago, the U.S. military decided to find out. Sitting on a $1 billion stockpile of drugs and facing the daunting process of destroying and replacing its supply every two to three years, the military began a testing program to see if it could extend the life of its inventory. The testing, conducted by the U.S. Food and Drug Administration, ultimately covered more than 100 drugs, prescription and over-the-counter. The results ... show that about 90% of them were safe and effective far past their original expiration date, at least one for 15 years past it. The program's returns have been huge. The military from 1993 through 1998 spent about $3.9 million on testing and saved $263.4 million on drug expense. In light of these results, a former director of the testing program, Francis Flaherty, says he has concluded that expiration dates put on by manufacturers typically have no bearing on whether a drug is usable for longer. "Manufacturers put expiration dates on for marketing, rather than scientific, reasons," says Mr. Flaherty, a pharmacist at the FDA until his retirement last year. "They want turnover." Joel Davis, a former FDA expiration-date compliance chief, says that with a handful of exceptions - notably nitroglycerin, insulin and some liquid antibiotics - most drugs are probably as durable as those the agency has tested for the military. "Most drugs degrade very slowly," he says. "In all likelihood, you can take a product you have at home and keep it for many years." Drug-industry officials ... acknowledge that expiration dates have a commercial dimension.

Note: As the Wall Street Journal charges to view this article at the above link, you can view it free here. For lots more on how the pharmaceutical industry cares more about profits than your health, click here.

A consortium of U.S. organic farmers and seed dealers filed suit against global seed giant Monsanto Co. on [March 29], in a move to protect themselves from what they see as a growing threat in the company's arsenal of genetically modified crops. The Public Patent Foundation filed the suit on behalf of more than 50 organizations challenging the chemical giant's patents on its genetically modified seeds. The group is seeking a ruling that would prohibit Monsanto from suing the farmers or dealers if their organic seed becomes contaminated with Monsanto's patented biotech seed germplasm. Monsanto has filed scores of lawsuits and won judgments against farmers they claimed made use of their seed without paying required royalties. Many farmers have claimed that their fields were inadvertently contaminated without their knowledge, and the issue has been a topic of concern for not only farmers, but also companies that clean and handle seed. "This case asks whether Monsanto has the right to sue organic farmers for patent infringement if Monsanto's genetically modified seed should land on their property," said Dan Ravicher, executive director of PUBPAT. The suit also alleges that Monsanto's GMO seeds do more harm than good and claims the patents on genetically modified seed are invalid because they don't meet the "usefulness" requirement of patent law.

Note: For a powerful, quality documentary revealing the gross abuses of Monsanto which endanger public health, click here.

The number of American children diagnosed with bipolar disorder increased 40-fold in a recent 10-year span, one study found. In Minnesota, spending on powerful antipsychotic drugs to treat bipolar and other disorders in children has risen 17-fold since 2000 and exceeds $6 million annually -- just in one state-funded health program. Now, in a medical reversal with few parallels, psychiatrists are backing away from the diagnosis. While some feel bipolar was once under-diagnosed in children, they worry that thousands of kids have since received the diagnosis in error, due to overzealous doctors, desperate parents, quirks in the health insurance system and aggressive marketing by drug companies. This summer, in a sign of the profession's second thoughts, the manual that psychiatrists use to make diagnoses is being rewritten and field-tested with a new disorder that would replace bipolar in many cases. The profession's about-face could help the next generation of troubled children, but it also raises questions about the harm done to children who shouldn't have received either the diagnosis or the potent drugs used to treat it. While antipsychotics can be lifesavers for patients who truly are bipolar, they come with increased risks of obesity, diabetes, muscle spasms and other serious side effects.

Note: For a powerful analysis of corruption in medicine by a leading medical researcher, click here. For key reports on health from reliable sources, click here.

An international study which debunks research linking cellphones to cancer risks received major funding from wireless manufacturers. The World Health Organization's International Agency for Research on Cancer classified [the] radio frequency emitted by wireless devices as possibly carcinogenic, but a panel of international scientists recently published a study challenging these findings. But in the study's conflict of interest disclaimer, the panel acknowledged it received support from the wireless industry to conduct the research. A number of organizations, including the Mobile Manufacturers' Forum, were cited as sources of funding. Dr. Devra Davis, an American scientist who runs the non-profit education group [Environmental Health Trust] says the new study is "misleading" and "wrong." "It is propaganda," said Davis, who also founded the world's first Center for Environmental Oncology. Davis says cellphone safety is a major public health issue and governments need to move away from the idea of taking action after there are "enough sick people or dead bodies." "The fact that we don't have an epidemic right now is of course what we expect," she said. "It is actually preposterous to imply or they really say that because don't have any increase now, there's no problem. It's really very sad."

Note: For more on the health threats posed by cell phones, click here.

There is an epidemic of cancer today. One in three Americans will be diagnosed with cancer, often before the age of 65. Since 1940, we have seen in Western societies a marked and rapid increase in common types of cancer. In fact, cancer in children and adolescents has been rising by 1 to 1.5 percent a year since the 1960's. And these are cancers for which there is no screening. For most common cancers - prostate, breast, colon, lung - rates are much higher in the West than in Asian countries. Yet Asians who emigrate to the United States catch up with the rates of Americans within one or two generations. While in Asia, Asians are protected not by their genes, but by their lifestyle. We continue to invest 97 percent of our cancer research funds in better treatments and early detection. Only 3 percent is invested in tackling causes. The World Cancer Research Fund published a report in 2007 concluding that a majority of cancer cases in Western societies could be avoided with life-style measures: 40 percent from changes in diet and physical activity (more vegetables and fruits, less sugar, less red meat, regular walking or the equivalent activity 30 minutes six times per week), 30 percent from smoking cessation, and about 10 percent from reduced alcohol consumption. We now even have data about how specific foods such as broccoli and cabbages, garlic and onions, green tea or the spice turmeric directly help kill cancer cells and reduce the growth of new blood vessels they need to develop into tumors.

Note: The author of this article, Dr. David Servan-Schreiber, is a clinical professor of psychiatry at the University of Pittsburgh and a founding board member of Doctors Without Borders, USA, and author of Anticancer - A new way of life. For an excellent, inspiring 10-minute video interview with this doctor, click here.

The food and advertising industries have launched a multi-pronged campaign to squash government efforts to create voluntary nutritional guidelines for foods marketed to children. Calling themselves the Sensible Food Policy Coalition, the nation’s biggest foodmakers, fast-food chains and media companies, including Viacom and Time Warner, are trying to derail standards proposed by four federal agencies. The U.S. Chamber of Commerce has also lent its lobbying muscle to the effort. The guidelines are designed to encourage foodmakers to reduce salt, added sugars and fats in foods and drinks targeted to children. Public-health experts say children, many of whom may lack the critical-thinking skills to understand advertising, are bombarded daily by television ads, Web sites, toy giveaways and cartoon characters promoting junk food. The food and beverage industry spends about $2 billion a year marketing directly to children. The business community has portrayed the government’s guidelines as job-killing government overreach. “We allow companies into our homes to manipulate children to want food that will make them sick,” said Margo Wootan of the Center for Science in the Public Interest.

Note: The "Sensible Food Policy Coalition" is arguing against voluntary guidelines designed to help our children eat more nutritious food. Is that Orwellian doublespeak or what?

What causes autism? Scientists still don't have an answer, but two new studies suggest that conditions in a mom's womb may trigger the developmental disorder. Heredity is considered a major factor that triggers autism spectrum disorders, but scientists have long wondered what roles - if any - environmental factors play. Scientists used California health records to identify 192 pairs of twins - fraternal or identical - where at least one was affected by autism. Using diagnostic techniques that included directly observing the children, the scientists found 77 percent of male identical twins and 50 percent of female identical pairs both had autism. Those findings weren't too surprising, considering identical twins share the same genes. But what surprised researchers were the high rates of autism spectrum disorders they found in pairs of fraternal twins: 31 percent rate for males and 36 percent for females. Fraternal twins, from two fertilized eggs, share no more genetic material than any other siblings. But since they share the same womb, that could play a role, said Dr. John Constantino, professor of psychiatry at the Washington University School of Medicine in St. Louis, who wasn't involved in the new research. Constantino calls the research a "key finding that puts a spotlight on pregnancy as a time when environmental factors might exert their effects."

Note: For major media articles presenting evidence of a link between autism and vaccines, click here.

For all those who've declared the autism-vaccine debate over a new scientific review begs to differ. It considers a host of peer-reviewed, published theories that show possible connections between vaccines and autism. The article in the Journal of Immunotoxicology is entitled "Theoretical aspects of autism: Causes--A review." The author is Helen Ratajczak, surprisingly herself a former senior scientist at a pharmaceutical firm. Ratajczak did what nobody else apparently has bothered to do: she reviewed the body of published science since autism was first described in 1943. Not just one theory suggested by research such as the role of MMR shots, or the mercury preservative thimerosal; but all of them. Ratajczak's article states, in part, that "Documented causes of autism include genetic mutations and/or deletions, viral infections, and encephalitis following vaccination. Therefore, autism is the result of genetic defects and/or inflammation of the brain." The article goes on to discuss many potential vaccine-related culprits, including the increasing number of vaccines given in a short period of time. Ratajczak also looks at a factor that hasn't been widely discussed: human DNA contained in vaccines. Ratajczak reports that about the same time vaccine makers took most thimerosal out of most vaccines (with the exception of flu shots which still widely contain thimerosal), they began making some vaccines using human tissue. Why could human DNA potentially cause brain damage? The way Ratajczak explained it to me: "Because it's human DNA and recipients are humans. That DNA is incorporated into the host DNA. Now it's changed, altered self and body kills it. Where is this most expressed? The neurons of the brain. Now you have body killing the brain cells and it's an ongoing inflammation." We asked Ratajczak how she came to research the controversial topic. She told us that for years while working in the pharmaceutical industry, she was restricted as to what she was allowed to publish. "I'm retired now," she told CBS News. "I can write what I want."

Note: For an excellent report endorsed by dozens of respected doctors and nurses on the serious risks and dangers of vaccines, click here. For other major media articles presenting evidence on the risks and dangers of vaccines, click here.

Physician Janette Sherman, M.D. and epidemiologist Joseph Mangano published a report Monday highlighting a 35% spike in northwest infant mortality after Japan's nuclear meltdown. The report spotlighted data from the CDC's Morbidity and Mortality Weekly Report on infant mortality rates in eight northwest cities, including Seattle, in the 10 weeks after Fukushima's nuclear meltdown. The average number of infant deaths for the region moved from an average of 9.25 in the four weeks before Fukushima' nuclear meltdown, to an average of 12.5 per week in the 10 weeks after. The change represents a 35% increase in the northwest's infant mortality rates. In comparison, the average rates for the entire U.S. rose only 2.3%.

Note: For details of this very important analysis of the CDC's data on US infant mortality after the Fukushima meltdowns, click here and here.

California Sen. Dianne Feinstein renewed a decadelong push [on June 17] to phase out the routine use of antibiotics in livestock, hogs and poultry. Government officials have warned that increasing antibiotic resistance in humans poses a serious public health threat. In the United States, the Food and Drug Administration has confirmed that 80 percent of all antibiotics are given to farm animals in low doses intended to stave off disease in large livestock operations. Many of the antibiotics are the same ones used to treat human diseases. Scientists have linked the practice to rising antibiotic resistance in humans, along with the overprescription of antibiotics by doctors. Feinstein's legislation, opposed by the National Pork Producers Council, would phase out the use of antibiotics considered "medically important" to humans and require new applications for animal antibiotics to prove that they do not endanger human health. The bill would permit antibiotics to treat sick animals. The California Democrat's bill is an identical version of a House bill, HR965, the Preservation of Antibiotics for Medical Treatment Act, by Rep. Louise Slaughter, D-N.Y., a microbiologist on a crusade to eliminate low-dose antibiotic use in livestock.

Note: For key reports on health issues from reliable sources, click here.

Cancer is not one disease. It is many. Yet oncologists have long used the same blunt weapons to fight different types of cancer: cut the tumour out, zap it with radiation or blast it with chemotherapy that kills good cells as well as bad ones. New cancer drugs are changing this. Scientists are now attacking specific mutations that drive specific forms of cancer. A breakthrough came more than a decade ago when Genentech, a Californian biotech firm, launched a drug that attacks breast-cancer cells with too much of a certain protein, HER2. In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein. Other drugs take different tacks. Avastin, introduced in America in 2004 by Genentech, starves tumours by striking the blood vessels that feed them. These new drugs sell well. Last year Gleevec grossed $4.3 billion. Roche’s Herceptin (the HER2 drug) and Avastin did even better: $6 billion and $7.4 billion respectively. The snag, from society’s point of view, is that all these drugs are horribly expensive. Last year biotech drugs accounted for 70% of the increase in pharmaceutical costs in America, according to Medco, a drug-plan manager. Cancer plays a huge role in raising costs.

Note: To see what happens when inexpensive potential cures for cancer are discovered, click here. For key reports on health issues from reliable sources, click here.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.